Risk infections and possibilities for biomedical terrorism /

Bibliographic Details
Corporate Authors:	North Atlantic Treaty Organization. Scientific Affairs Division, NATO Advanced Research Workshop on Risk Infections and Possibilities for Biomedical Terrorism
Other Authors:	Elzer, Philip H., Metodiev, Krassimir T.
Format:	Conference Proceeding Book
Language:	English
Published:	Amsterdam ; Washington, DC : IOS Press, [2004]
Series:	NATO science series. Life and behavioural sciences. v. 361.
Subjects:	Bioterrorism. Biological Warfare. Congresses.

Table of Contents:

A review on bioterrorism, definition, history, current state, future threats
Organization of military medical response to bioterroristic attacks
Zoonotic bacterial agents and their roles in biological and agricultural terrorism
Application of genomics and proteomics for detection assay development for biological agents of mass destruction
Clinical aspects of anthrax
Mass trauma in Jerusalem
Screening Bulgarian medicinal plant extracts for antioxidant activity
BioSensing technologies
Severe acute respiratory syndrome (SARS)
Immunotoxicity and sensitizing capacity of metal compounds depend on speciation
Patient empowerment
Cross-infection in dentistry prevention and control
Biological weapons - risk assessment of use
The experience of the Center Military Psychology and Prevention in the Psychological Support of the Peace-Keeping Forces of NATO and UN
An assessment of the potential of amplified-fragment length polymorphism (AFLP) for use in identification and typing of Brucella isolates
Can blood products be used for bioterrorism?
Antibiotics : modes of action, resistance mechanisms and the search for new compounds
An assessment of the levels of harmful substances in the atmospheric air in an ecologically polluted region
Chemokines
Status of the sea water in the bathing zone of the Varna Sea Coast
Anaerobic surgical infection as possible mode of bioterrorism
Characteristics of chronic hepatitis C viral infection for the region of Varna
Experimental attempt to introduce a vaccine therapy by using DC-developed from CD34₊ cells
Validation of rapid diagnostics for foreign and emerging animal diseases in the United States
Bioterrorism and biosensors in the microbiological laboratory